Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2025-03-13 Investor Presentation
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
114年03月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's scheduled '法人說明會' which translates to 'investor presentation' or 'analyst briefing'. It includes the date, time, location, and links to presentation materials and videos. The description mentions the company will explain publicly released financial numbers and operational overview, typical of an investor presentation. The document is short (975 characters) and does not contain actual financial statements or detailed analysis, but rather information about the event and related materials. Therefore, it is best classified as an Investor Presentation (IP).
2025-03-13 Chinese
113年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment income, and investment limits approved by the Ministry of Economic Affairs. The document is relatively short (1485 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an annual or quarterly report, audit report, or earnings release. Instead, it fits the profile of a Regulatory Filing (RNS) as it is a regulatory disclosure of investment information required by authorities, without being a full financial report or announcement of a report publication.
2025-03-13 Chinese
113年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (113th year, 4th quarter). The content is tabular financial data but very brief (only 766 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or a certification. Given the nature and brevity, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-03-13 Chinese
114年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information on loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (620 characters) and does not present a comprehensive financial report or detailed analysis. It appears to be a regulatory disclosure of specific financial data rather than a full report or announcement of a report. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-03-07 Chinese
114年2月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary revenue report from a listed company (神隆) showing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting requirements. The content is a brief financial summary without detailed financial statements or management discussion. The document length is short (774 characters) and it appears to be a regulatory disclosure of financial data rather than a full report. It does not contain comprehensive financial statements or detailed analysis typical of Annual Reports (10-K) or Interim Reports (IR). It is also not an announcement of a report publication but a direct disclosure of financial figures. Given the nature and format, this fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-07 Chinese
公告台灣神隆股份有限公司舉行2024全年法人說明會
Investor Presentation Classification · 90% confidence The document is a short announcement (675 characters) about the scheduling of a 2024 full-year investor presentation (法人說明會) by the company Taiwan Shenlong Co., Ltd. It specifies the date, time, and location of the event and mentions that the company will explain already publicly released financial data and operational overview. There is no actual financial data or detailed presentation content included in the text. The document serves as a notice of the event rather than the event materials or report itself. According to the rules, such announcements about upcoming investor presentations are classified as Investor Presentation (IP) if they contain the presentation itself, but here it is only an announcement of the event. However, since it is specifically about the investor presentation event, and not a general regulatory filing or report publication announcement, the best fit is Investor Presentation (IP) category, as it relates directly to the investor presentation event. Confidence is high given the clear description of the event and absence of other report types.
2025-03-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.